BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19141454)

  • 1. Production of protective gamma interferon by natural killer cells during early mouse hepatitis virus infection.
    Thirion G; Coutelier JP
    J Gen Virol; 2009 Feb; 90(Pt 2):442-447. PubMed ID: 19141454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the inflammasome-related cytokines Il-1 and Il-18 during infection with murine coronavirus.
    Zalinger ZB; Elliott R; Weiss SR
    J Neurovirol; 2017 Dec; 23(6):845-854. PubMed ID: 28895072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CXC chemokine ligand 10 from the mouse hepatitis virus genome results in protection from viral-induced neurological and liver disease.
    Walsh KB; Edwards RA; Romero KM; Kotlajich MV; Stohlman SA; Lane TE
    J Immunol; 2007 Jul; 179(2):1155-65. PubMed ID: 17617609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine coronavirus-induced subacute fatal peritonitis in C57BL/6 mice deficient in gamma interferon.
    Kyuwa S; Tagawa Y; Shibata S; Doi K; Machii K; Iwakura Y
    J Virol; 1998 Nov; 72(11):9286-90. PubMed ID: 9765476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4 T-cell-mediated demyelination is increased in the absence of gamma interferon in mice infected with mouse hepatitis virus.
    Pewe L; Haring J; Perlman S
    J Virol; 2002 Jul; 76(14):7329-33. PubMed ID: 12072531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the p60 autolysin enhances NK cell activation and is required for listeria monocytogenes expansion in IFN-gamma-responsive mice.
    Humann J; Bjordahl R; Andreasen K; Lenz LL
    J Immunol; 2007 Feb; 178(4):2407-14. PubMed ID: 17277147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
    Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A
    Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells.
    Trifilo MJ; Montalto-Morrison C; Stiles LN; Hurst KR; Hardison JL; Manning JE; Masters PS; Lane TE
    J Virol; 2004 Jan; 78(2):585-94. PubMed ID: 14694090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Important roles for gamma interferon and NKG2D in gammadelta T-cell-induced demyelination in T-cell receptor beta-deficient mice infected with a coronavirus.
    Dandekar AA; O'Malley K; Perlman S
    J Virol; 2005 Aug; 79(15):9388-96. PubMed ID: 16014902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic endothelial and Kupffer cells involved in immunosuppressive cytokines and natural killer (NK)/NK T cell disorders in viral acute hepatitis.
    Jacques A; Bleau C; Martin JP; Lamontagne L
    Clin Exp Immunol; 2008 May; 152(2):298-310. PubMed ID: 18336588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system, but not the liver.
    Matthews AE; Weiss SR; Shlomchik MJ; Hannum LG; Gombold JL; Paterson Y
    J Immunol; 2001 Nov; 167(9):5254-63. PubMed ID: 11673540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma).
    Sun R; Gao B
    Gastroenterology; 2004 Nov; 127(5):1525-39. PubMed ID: 15521020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perforin-mediated effector function within the central nervous system requires IFN-gamma-mediated MHC up-regulation.
    Bergmann CC; Parra B; Hinton DR; Chandran R; Morrison M; Stohlman SA
    J Immunol; 2003 Mar; 170(6):3204-13. PubMed ID: 12626579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-gamma is required for viral clearance from central nervous system oligodendroglia.
    Parra B; Hinton DR; Marten NW; Bergmann CC; Lin MT; Yang CS; Stohlman SA
    J Immunol; 1999 Feb; 162(3):1641-7. PubMed ID: 9973424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perforin and gamma interferon-mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cells.
    Bergmann CC; Parra B; Hinton DR; Ramakrishna C; Dowdell KC; Stohlman SA
    J Virol; 2004 Feb; 78(4):1739-50. PubMed ID: 14747539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insertion of the CXC chemokine ligand 9 (CXCL9) into the mouse hepatitis virus genome results in protection from viral-induced encephalitis and hepatitis.
    Muse M; Kane JA; Carr DJ; Farber JM; Lane TE
    Virology; 2008 Dec; 382(2):132-44. PubMed ID: 18973912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system.
    Liu MT; Armstrong D; Hamilton TA; Lane TE
    J Immunol; 2001 Feb; 166(3):1790-5. PubMed ID: 11160225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.
    Orange JS; Wang B; Terhorst C; Biron CA
    J Exp Med; 1995 Oct; 182(4):1045-56. PubMed ID: 7561678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. γδ T Cells Contribute to the Outcome of Murine Fulminant Viral Hepatitis via Effector Cytokines TNF-α and IFN-γ.
    Wu D; Yan WM; Wang HW; Huang D; Luo XP; Ning Q
    Curr Med Sci; 2018 Aug; 38(4):648-655. PubMed ID: 30128874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference of natural mouse hepatitis virus infection with cytokine production and susceptibility to Trypanosoma cruzi.
    Torrecilhas AC; Faquim-Mauro E; Da Silva AV; Abrahamsohn IA
    Immunology; 1999 Mar; 96(3):381-8. PubMed ID: 10233719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.